Bioventix (LON:BVXP) Reaches New 52-Week Low – Time to Sell?

Bioventix PLC (LON:BVXP) shares reached a new 52-week low on Thursday . The company traded as low as GBX 2,905 ($36.04) and last traded at GBX 2,998 ($37.19), with a volume of 7773 shares traded. The stock had previously closed at GBX 3,025 ($37.53).

Bioventix Price Performance

The stock’s 50-day moving average price is GBX 3,286.74 and its 200-day moving average price is GBX 3,737.31. The company has a market cap of £157.64 million, a P/E ratio of 1,852.76 and a beta of 0.35.

Insider Buying and Selling at Bioventix

In other news, insider Bruce Hiscock acquired 24 shares of the stock in a transaction dated Friday, November 22nd. The stock was bought at an average price of GBX 3,822 ($47.41) per share, with a total value of £917.28 ($1,137.92). Insiders own 8.02% of the company’s stock.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.